General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy.

Tada T, Kurosaki M, Tamaki N, Yasui Y, Mori N, Tsuji K, Hasebe C, Joko K, Akahane T, Furuta K, Kobashi H, Fujii H, Ishii T, Marusawa H, Kondo M, Kojima Y, Yoshida H, Uchida Y, Nakamura S, Izumi N

Open source

DOI: 10.1002/jgh3.12778
Published: 2022 Jul
Container: JGH open : an open access journal of gastroenterology and hepatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jgh3.12778,
  title = {General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy.},
  author = {Tada T and Kurosaki M and Tamaki N and Yasui Y and Mori N and Tsuji K and Hasebe C and Joko K and Akahane T and Furuta K and Kobashi H and Fujii H and Ishii T and Marusawa H and Kondo M and Kojima Y and Yoshida H and Uchida Y and Nakamura S and Izumi N},
  year = {2022},
  journal = {JGH open : an open access journal of gastroenterology and hepatology},
  doi = {10.1002/jgh3.12778},
  url = {https://doi.org/10.1002/jgh3.12778}
}

RIS

TY  - JOUR
TI  - General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy.
AU  - Tada T
AU  - Kurosaki M
AU  - Tamaki N
AU  - Yasui Y
AU  - Mori N
AU  - Tsuji K
AU  - Hasebe C
AU  - Joko K
AU  - Akahane T
AU  - Furuta K
AU  - Kobashi H
AU  - Fujii H
AU  - Ishii T
AU  - Marusawa H
AU  - Kondo M
AU  - Kojima Y
AU  - Yoshida H
AU  - Uchida Y
AU  - Nakamura S
AU  - Izumi N
PY  - 2022
JO  - JGH open : an open access journal of gastroenterology and hepatology
DO  - 10.1002/jgh3.12778
UR  - https://doi.org/10.1002/jgh3.12778
ER  -

APA

T, T., M, K., N, T., Y, Y., N, M., K, T., C, H., K, J., T, A., K, F., H, K., H, F., T, I., H, M., M, K., Y, K., H, Y., Y, U., S, N., & N, I. (2022). General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy.. JGH open : an open access journal of gastroenterology and hepatology. https://doi.org/10.1002/jgh3.12778

Source records

pubmed · retrieved 2026-09-26T09:34:09.984Z